Truncated isoform Vav3.1 is highly expressed in ovarian cancer stem cells and clinically relevant in predicting prognosis and platinum‐response

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0215|142|8|1640-1651

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.142, Iss.8, 2018-04, pp. : 1640-1651

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retrospective Analyses of Cancer Trials or Existing Clinical Databases: Potential for Highly Clinically Relevant Hypothesis Generation

By  

Oncology, Vol. 83, Iss. 6, 2012-09 ,pp. : 329-330

Karger

Access to resources Recommend Favorite

Clinically relevant aspects of stem cell technologies: current state of play

By  

ANZ JOURNAL OF SURGERY, Vol. 85, Iss. 9, 2015-09 ,pp. : 615-619

John Wiley & Sons Inc

Access to resources Recommend Favorite

Topotecan and Gemcitabine in Platinum/Paclitaxel-Resistant Ovarian Cancer

By  

Oncology, Vol. 60, Iss. 1, 2000-12 ,pp. : 19-23

Karger

Access to resources Recommend Favorite

Molecular Signatures of Ovarian Cancer: From Detection to Prognosis

By Walsh Christine S.   Karlan Beth Y.  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 1, 2010-02 ,pp. : 13-22

Adis International

Access to resources Recommend Favorite

Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer

By  

Oncology, Vol. 90, Iss. 2, 2016-0 ,pp. : 59-68

Karger

Access to resources Recommend Favorite